Jak-Inhibitors in Dermatology

個数:

Jak-Inhibitors in Dermatology

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 165 p.
  • 言語 ENG
  • 商品コード 9783031842733
  • DDC分類 616.5

Full Description

This book covers the clinical usage of JAK inhibitors, which target Janus kinases and have shown promising results in the treatment of various dermatologic conditions, including atopic dermatitis, psoriasis, vitiligo, connective tissue disorders, autoimmune bullous diseases and alopecia areata. It is likely that JAK inhibitors will continue to play an important role in the management of these conditions, with clinical trials ongoing to assess their safety and efficacy in the treatment of other dermatologic disorders, such as vitiligo and hidradenitis suppurativa. However, it is important to note that JAK inhibitors can have potential side effects, including increased risk of infections, anemia and thrombosis. Therefore, careful monitoring of patients receiving JAK inhibitors is necessary to ensure their safety.

Jak Inhibitors in Dermatology represents a treatise on this novel topic and discusses that while JAK inhibitors have shown great promise in the treatment of various dermatologic conditions, further research and monitoring is necessary to fully understand their potential benefits and risks. This book is therefore of great interest for all dermatologists as a first step to understanding this novel treatment.

Contents

History of The Jak/Stat Pathway.- Structures of Jak Inhibitors.- Basic Pharmacology and Pharmacokinetics of Jak-Stat Inhibitors.- Mechanism of Action.- Pan-Jak Inhibitors / Non-Selective Jak Inhibitors.- Selective Jak Inhibitor: Abrocitinib (Jak1-Selective).- Selective Jak Inhibitor: Ritlecitinib.- Selective Jak Inhibitor: Upadacitinib (Jak1-Selective).-  Novel Jak Inhibitors.- Dermatological Indications: Atopic Dermatitis.- Dermatological Indications: Alopecia Areata.- Dermatological Indications: Psoriasis.- Dermatological Indications: Vitiligo.- Dermatological Indications: E-Other Dermatological Indications.- Topical Jak Inhibitors.- Safety, Toxicity Profile, and Side Effects.- Jak Inhibitors/Drug Interactions.- Use of Jak Inhibitors in Dermatology Under Special Conditions.- The Future of Jak Inhibitors in Dermatology.- Conclusion.- Index.

最近チェックした商品